Leap Therapeutics (NASDAQ:LPTX – Get Free Report) was downgraded by Baird R W from a “strong-buy” rating to a “hold” rating in a research note issued on Wednesday,Zacks.com reports. Several other ...

Research analysts at Raymond James decreased their FY2024 EPS estimates for shares of Canadian National Railway in a research note issued on Monday, January 27th. Raymond James analyst S. Hansen now ...

Leap To Fame holds a 3-1 advantage over Swayzee after winning their past three clashes, but Hart believes the barrier draw and gruelling 2760m trip give him a chance to “get one back” in Victoria’s ...

Leap, a full-stack international student mobility platform, has raised $65 million through a mix of primary and secondary ...

The most recent announcement from Laowa is not a new lens but the release of the company’s new short film, The Leap Beneath, ...

When we came upon this area, I told my husband to stop. I took a few shots, and this was my favorite,' Wendy Hampe said.

The Series E funding round also saw participation from existing investors Owl Ventures, Jungle Ventures, and Peak XV Partners ...

The startup, which helps students study abroad, plans to enter China, Malaysia and Taiwan, in addition to building a deeper presence in Bangladesh, Sri Lanka, West Asia, and Southeast Asia. Leap also ...

Fintel reports that on January 29, 2025, HC Wainwright & Co. downgraded their outlook for Leap Therapeutics (NasdaqCM:LPTX) ...

Last week, we looked at occurrences at Lover’s Leap from 1915 through 1938; this week we will cover from the forties to the ...

Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...

H.C. Wainwright adjusted its stance on Leap Therapeutics (NASDAQ:LPTX), downgrading the biopharmaceutical company's stock ...